Diphtheria toxin is a polypeptide of 535 residues produced and secreted by Corynebacterium diphtheriae. Receptors for this toxin are present on most mammalian cells; 30 once inside the cell, the polypeptide is extremely toxic because it inhibits host cell protein synthesis through adenosine diphosphate (ADP) ribosylation of elongation factor-2. 32 As little as one molecule of fully active diphtheria toxin may be sufficient to abolish protein synthesis and provoke cell death. 37 The diphtheria toxin A fragment (DTA; amino acids ) is the catalytic component of the toxin and is responsible for its toxicity; the B fragment (amino acids 194-535) mediates entry into the host cell by binding specific cellular receptors that facilitate translocation of the toxin into the cytoplasm. 23 Because of the widespread distribution of diphtheria toxin receptors on most cells, therapeutic approaches have been devised that deliver DTA selectively to neoplastic cells, avoiding binding to, and killing of, normal cells. For example, DTA and other protein toxins have been conjugated to monoclonal antibodies that recognize cell surface antigens or to ligands for cellular receptors expressed selectively on neoplastic cells. 8, 31 Effective cell killing has also been accomplished using direct transfection of the DTA gene into tumor cells.
In contrast to most drug-conditional cytotoxic therapies, bacterial toxins can kill cells at extremely low concentrations, do not require cell replication for killing, and do not depend on exogenously applied compounds that may display general toxicity, such as ganciclovir. However, because bacterial toxins can act directly on cellular metabolism, tissue specificity and the timing and level of expression must be stringently regulated in a clinical setting. Therefore, in devising approaches that involve the delivery of toxin genes to tumor cells, accurate and efficient mechanisms to control toxin gene expression must be developed.
The use of inducible eukaryotic promoters, such as the metallothionein and mouse mammary tumor virus promoters, for the control of gene expression has been hindered by their limited increases on induction and the pleiotropic effects of the inducers, heavy metals, and steroids. 11 In contrast, prokaryotes harbor several transcription systems that can stringently and specifically regulate gene expression through the actions of physiological inducers and inhibitors. In the Escherichia coli lactose (lac) operon, the lac repressor protein (lacR, encoded by the lacI gene) binds as a homotetramer to lac operator sequences (lacO) downstream of the lac promoter, leading to inhibition of transcription of the lacZ, lacY, and lacA genes. Physiological inducers (allolactose) or synthetic inducers (IPTG) bind to lacR and cause a conformational change and decrease in affinity for lacO, resulting in dissociation of the lacO/lacR complex and induction of transcription. 36 Similarly, in the tetracycline (tet) resistance operon of E. coli, the tet repressor (tetR) inhibits transcription of tetracycline resistance-mediating genes by binding to the tet operator (tetO), whereas tetracycline as the physiological inducer reestablishes transcription by removing tetR from tetO. 18 Both the Lac and Tet systems have been adapted for use in mammalian cells. In the Lac system, a modified form of lacR, containing a nuclear localization signal, was shown to downregulate the expression of a cotransfected gene under the control of a promoter containing lacO sequences. 3, 15, 19 Furthermore, expression of the cotransfected gene was inducible with isopropyl-thio-␤-D-galactoside (IPTG). An interesting modification was introduced into the Tet system for its use in mammalian cells by Gossen and Bujard. 13 By fusing tetR with the transcriptional activating domain of virion protein 16 (VP16) of the herpes simplex virus, a tetracycline-controlled transactivator (tTA) was generated. This tTA still efficiently binds tetO sequences and tetracycline; however, rather than repressing transcription, tTA now activates transcription because positively acting cellular transcription factors are recruited by the VP16 activating domain. 1 The tTA has been shown to stimulate transcription of a minimum promoter containing tetO sequences by up to five orders of magnitude in cultured mammalian cells and transgenic mice. 10, 13 Furthermore, in the presence of tetracycline, which removes tTA from tetO, transcription from the minimum promoter can be repressed.
Here we show that prokaryotic transcription control systems are able to modulate the expression of DTA in human glioma cells and, consequently, the rate of tumor cell killing by up to 120-fold. We found that the Tet system was superior to the Lac system in controlling toxin gene expression. More generally, our data indicate that prokaryotic transcription control elements are promising tools for achieving regulated expression of therapeutic genes.
Materials and Methods

The Plasmids
A 635-bp DTA fragment encoding the DTA subunit was generated using polymerase chain reaction (PCR) from pTH-1. 26 Included in the 5Ј PCR primer was an optimal Kozak sequence (CCA-CCATG) for efficient translation initiation. The PCR-generated DTA fragment was inserted into the cloning vector pCRII and designated pCR-DTA.
The Tet system expression vectors include the regulator plasmid pUHD15-1 encoding tTA, which is under the transcriptional control of a human cytomegalovirus (hCMV) promoter/enhancer, and the response plasmid pUHD10-3, which includes a minimum hCMV promoter that is tTA dependent because of heptamerized upstream tetracycline operators. 13 The DTA was excised from pCR-DTA by Eco RI digestion and ligated into the unique Eco RI site of pUHD10-3 to construct the response plasmid pUHD-DTA.
The Lac system vectors include the regulator plasmid p3ЈSS, which contains a modified lacI gene under control of a polyoma F9-1 promoter, and the plasmid pOPI3CAT, which contains three ideal (Oid) 20-bp lacO sequences embedded within an SV40 intron downstream of the RSV-LTR promoter (LacSwitch system). The DTA fragment was excised from pCR-DTA with EagI and ligated into the NotI site of pOPI3CAT to construct the response plasmid pOP-RSV-DTA.
To replace the RSV-LTR promoter of pOP-DTA by the heavy metal-inducible mouse metallothionein-1 (MT-1) promoter, the RSV-LTR promoter was excised with SnaBI and BglII. The remaining 6327-bp fragment was ligated to a 564-bp PvuII/BamHIgenerated fragment containing the MT-1 promoter and an additional 25-bp O1 lacO immediately downstream of the promoter. The MT-1 promoter was generated by PCR using pCLH3A 34 as the template and ligated into pCRII. The resulting construct containing four lac operators was named pOP-MT1-DTA.
Using p3ЈSS as the template, pMFGlac was constructed by PCR amplification of the entire lacI transcriptional unit. The 1990-bp PCR product included the F9-1 promoter at the 5Ј end and the thymidine kinase polyadenylation signal at the 3Ј end. The NcoI and BamHI restriction sites were included in the PCR primers to facilitate cloning into the NcoI and BamHI sites of the retroviral vector pMFG. 7 Both pSVLuc 25 and pGL2 are expression plasmids that code for firefly luciferase under control of the SV40 promoter/enhancer.
Cell Lines
The human glioblastoma cell lines, U-87MG and U-343MG, were maintained in Dulbecco's modified Eagle's minimum essential medium supplemented with 10% fetal calf serum and 100 U/ml penicillin G/100 g/ml streptomycin sulfate.
Establishment of lacR-Expressing Clones (U-343lac Cells)
The U-343MG cells were plated at a density of 10 5 cells per 100-mm dish and incubated for 24 hours until a confluency of 60% was reached. One hour after addition of fresh medium, the cells were cotransfected with 12 g pMFGlac and 3 g pRSVneo (encoding the neomycin resistance gene) using the calcium phosphate technique. After 6 hours, cells were washed twice in phosphate-buffered saline. Forty-eight hours after transfection, the cells were split 1:5 into 100-mm dishes and selected in medium containing 400 g/ml G418. The G418-resistant clones were expanded and screened for lacR expression using Western blotting analysis. From each clone, total cell lysates were prepared, 16 protein concentration was determined using a DC protein assay kit, and sample buffer (50 mM TrisHCl pH 6.8/2% glycerol, 5% 2-mercaptoethanol, 0.01 mg/ml bromophenol blue) was added to each sample (50 g). Samples were then resolved by electrophoresis in 10% sodium dodecyl sulfatepolyacrylamide gels. Proteins were transferred to nitrocellulose, probed overnight with a rabbit anti-lacR antibody (diluted 1:1000), and developed using an indirect immunoperoxidase system and chemiluminescence. Proteins extracted from the E. coli strain DH5␣ served as a positive control for lacR.
Transient Transfections With DTA Plasmids
The U-87MG cells (10 6 , Lac and Tet systems) or the U-343lac cells (3 ϫ 10 5 , Lac system) were plated onto 100-mm dishes. Transient transfections using the calcium phosphate technique were performed the following day 1 hour (Lac system) or 3 hours (Tet system) after washing. The U-87MG cells were preincubated with tetracycline at various concentrations 3 hours before transfection. The IPTG was added to U-87MG cells and to U-343lac cells at various concentrations 6 hours after transfection. Tetracycline and IPTG were present until harvesting. Luciferase assays were performed 24 hours posttransfection.
The pUHD-DTA and pOP-DTA plasmid DNAs were cotransfected with the appropriate regulator plasmids, together constituting 20 g, at different ratios into U-87MG cells. In addition, 10 g of luciferase plasmid DNA was used in all transfections for quantification of cell killing. 24, 26 For the Lac system, pGL2 was used instead of pSVLuc as the reporter plasmid because the latter contains lacO sequences responsive to lacR/IPTG. To investigate the effects of the regulator-containing plasmids and the basal activity of the promoters responsible for expression of DTA, pUHD15-1 and p3ЈSS were replaced by equal amounts of pRK5, which lacks tetO and lacO regulatory sequences.
14 The U-343lac cells were transfected with different amounts of pOP-DTA plasmid DNA, and the total amount of transferred DNA was equalized by addition of the parent vector, pOPI3CAT. Identical precipitates were used for the transfections with or without addition of tetracycline or IPTG. All transfections were done in duplicate and performed at least twice.
Luciferase Assay
Cells were washed three times with PBS before they were lysed in 1 mM dithiothreitol/1% Triton X-100/luciferase buffer (25 mM glycylglycine, 15 mM MgSO 4 , 4 mM ethyleneglycolibis (␤-aminoethyleter)-N,NЈ-tetraacetic acid, pH 7.8) at 4˚C. 17 Cell lysates were scraped off the dishes and centrifuged for 4 minutes at 7800 g. Aliquots (100 l) of the supernatant were mixed with 370 l luciferase buffer containing 2 mM adenosine triphosphate, 1 mM dithiothreitol, and 15 mM potassium phosphate, and assayed for luciferase activity in a 1251 luminometer using the integral mode. The D-Luciferin was used at a saturating substrate concentration (0.2 mM in luciferase buffer). Luciferase activity was adjusted to protein content of the lysates, as determined using a DC protein assay kit.
Sources of Supplies and Equipment
The U-87MG and U-343MG cell lines were obtained from the American Type Culture Collection (Rockville, MD) and from Dr. Mark Israel (University of California at San Francisco, San Francisco, CA), respectively.
The plasmids pUHD10-3 and pUHD15-1 were kindly provided by Dr The cloning vector pCRII was purchased from Invitrogen (San Diego, CA). The LacSwitch System was obtained from Stratagene (La Jolla, CA), which also provided the anti-lacR antibody and the IPTG. The control vector pGL2 was obtained from Promega (Madison, WI). Vector (Burlingame, CA) provided the indirect immunoperoxidase system. The enhanced chemiluminescence (ECL) was provided by Amersham (Little Chalfon, England). The G418 and the DH5␣ were obtained from Life Technologies (Basel, Switzerland). The DC protein assay kit was obtained from Bio-Rad (Hercules, CA).
In the luciferase assay, we used a 1251 luminometer provided by Wallac (Gaithersburg, MD). The D-Luciferin was purchased from Sigma Chemical Co. (St. Louis, MO).
Results
Regulation of DTA Gene Expression Using the Tet System
We generated plasmid-based expression vectors containing the DTA gene under the control of the Tet system (Fig. 1 upper) . Regulation and induction of the DTA gene in this system were examined in transient transfection assays involving cotransfection of a "regulator" plasmid (encoding tTA), a "response" plasmid (tTA-dependent promoter in front of the DTA gene), and an "indicator" plasmid (encoding luciferase under the control of the SV40 promoter) (Fig. 1 upper) . The rationale for the indicator plasmid is that the degree of expression of the luciferase gene provides a highly sensitive means of measuring expression of the DTA gene as well as the effectiveness of the DTA protein to abolish protein synthesis by ADP ribosylation of elongation factor-2. a significant decrease in luciferase activity in the absence of tetracycline (< 1% of the activity observed with the luciferase-indicator plasmid alone) (Fig. 2 left) . In identical cotransfections, performed in the presence of 1 g/ml tetracycline (which should repress DTA gene expression), luciferase activities were partially restored. Specifically, depending on the ratio of the DTA-response and tTA-regulator plasmids used in the transfection, luciferase activities ranged between 46% and 6% of activity obtained in transfections with luciferase-indicator plasmid alone (Fig.  2 left) . These results demonstrate that tetracycline can regulate binding of the tTA protein to the response elements and regulate the expression of DTA. Moreover, the "fold" induction, determined by dividing the luciferase activity in the repressed state (with tetracycline) by the luciferase activity in the induced state (without tetracycline), ranged from 120-fold to twofold (Fig. 2 left and Table 1 ), the greatest degree of regulation being obtained at a 1:100 ratio of DTA-response and tTA-regulator plasmids. The use of lower tetracycline concentrations (0.001 g/ml, 0.01 g/ml, or 0.1 g/ml) did not significantly increase regulation, whereas higher concentrations (10 g/ml) were cytotoxic (data not shown).
Regulation of DTA Gene Expression Using the Lac System
We also generated plasmid-based expression vectors containing DTA under the control of the RSV-LTR promoter to which lacO sequences have been added (Fig. 1  lower) . In contrast to the Tet system in which expression of DTA is stimulated when the tTA protein binds tetO sequences, expression of DTA in the Lac system should be abolished when lacR binds lacO sequences and restored when IPTG is added because of the dissociation of lacR from lacO sequences.
Transfections of U-87MG cells with the luciferase-indicator plasmid and different ratios of the DTA-response plasmid pOP-RSV-DTA and the regulator-plasmid p3ЈSS (which should repress DTA gene transcription in the absence of IPTG) resulted in luciferase activity ranging from 35 to 2% of the values obtained in transfections with luciferase-indicator plasmid alone (Fig. 2 right) . Addition of IPTG (5 mM) had only a small effect on induction of DTA gene expression. The fold induction, determined by dividing the luciferase activity in the repressed state (without IPTG) by the luciferase activity in the induced state (with IPTG), did not exceed twofold and thus was much lower than those obtained using the Tet system ( Fig. 2  right and Table 1 ). Concentrations of IPTG at 1 mM and 10 mM did not increase the fold induction, whereas toxic effects were observed at an IPTG concentration of 25 mM (data not shown).
Two additional strategies were used to improve the low induction ratios of the Lac system. First, a glioma cell line that constitutively overexpresses lacR was generated to prevent possible toxic effects of DTA that occur prior to the synthesis of sufficient amounts of lacR; this potentially could be occurring in the transient transfection experiments. Following cotransfection of U-343MG cells with pMFGlac ( Fig. 1) and pRSVneo, several G418-resistant clones were tested for stable lacR expression. The immunoblotting results of three of these clones are shown in Fig. 3 . A strong band of approximately 38 kD was seen in one of the clones (designated U-343lac), was absent in the parental cell line (U-343MG), and corresponded to the 38-kD band of monomeric lacR present in protein extract from the E. coli strain DH5␣. When U-343lac cells were transfected with increasing amounts of the DTA-response pOP-RSV-DTA plasmid, IPTG induction increased only moderately to at best threefold (Fig. 4 and Table 1 ). The second strategy involved replacement of the RSV-LTR promoter responsible for DTA gene expression with the MT-1 promoter. Lower basal DTA expression due to the less active MT-1 promoter (in the absence of heavy metals), as well as an additional lac operator, might result in better regulation. After transfection of pOP-MT1-DTA into U-343lac cells, luciferase activity remained relatively high (73% of the activity obtained with luciferase plasmid alone), indicating lower toxin expression by the MT-1 promoter in the repressed state. However, induction of DTA gene expression was still low (two-to threefold using 5 mM IPTG and 0.5 M ZnSO 4 ; Table 1 ).
Discussion
To regulate the expression of transferred toxin genes in neoplastic cells effectively, inducible systems require several features. Ideally, in the induced state, the concentration of the toxin should be high enough to guarantee killing of all transfected cells and the basal activity in the repressed or noninduced state should be low enough to prevent cell damage. Our data show that these requirements are potentially fulfilled by the Tet system, but not by the Lac system.
In the induced state, both systems were highly effective at abolishing protein synthesis. Using the Lac system, luciferase activity was decreased to less than 2%, but only after transfection of the highest amount of DTA plasmid. In contrast, the Tet system showed reduced luciferase activity to less than 1%, even after transfecting the lowest amount of DTA plasmid. The almost complete inhibition of protein synthesis in transfected cells 24 hours posttransfection reveals the extreme toxicity of DTA and its rapid action, which is independent of cellular replication.
When DTA expression was repressed in the two regulated systems (with tetracycline or in the absense of IPTG), luciferase activity was reduced by only 29% in the Tet system but by more than 65% in the Lac system. The reduction in luciferase activity indicates that low-level basal expression from the RSV-LTR and minimum hCMV promoters does occur in both systems. In accordance with these findings, low basal luciferase expression has also been observed in some tissues of mice that are transgenic for the luciferase gene under control of the tTA-responsive minimal hCMV promoter. 10 The more pronounced degree of basal expression in the repressed state of the Lac system is explained by the relatively high basal activity of MT-1/lacO and RSV/lacO promoters used. The low basal or "leaky" DTA expression we observed in our studies with the Tet system can be circumvented in two different ways. 1) We have recently constructed a novel retroviral vector in which the Tet system components were incorporated in a manner that decreases basal or leaky expres- 2.3 * In the Tet system, optimal regulation is dependent on the ratio between the amounts of cotransfected tTA and DTA plasmids, whereas the low regulation of the Lac system cannot be markedly increased by different DTA:lacI plasmid ratios. sion. 33 Using this vector, we have achieved controlled induction of apoptotic cell death of glioma cells in vitro and in vivo by transferring and tightly regulating the interleukin-1␤-converting enzyme gene. 38 Similarly, the retroviral Tet system may be effective at delivering and more stringently controlling the expression of DTA in tumor cells. 2) In the studies described here we used a fully functional DTA gene; however, a spectrum of attenuated DTA mutants have recently become available that demonstrate 10 to 10,000 times decreased elongation factor-2 ADP ribosylation activities. 21 If a small amount of basal expression in the Tet system is unavoidable, a mutant and less active DTA coupled with the Tet system could be used rather than the fully active toxin in a tumor-killing paradigm.
Using the commercially available Lac system, the induction ratio, calculated as the ratio of luciferase activity in the repressed versus induced states, did not exceed twofold in our transient transfection experiments, whereas a five-to 30-fold induction by IPTG has previously been reported using various other Lac systems. 3, 15, 19 We therefore introduced two modifications in hopes of increasing IPTG-dependent regulation and decreasing high basal activity in the Lac system. First, we generated a U-343MG subclone that constitutively expresses lacR to account for possible DTA toxicity occurring prior to lacR synthesis and to increase intracellular levels of lacR to ensure that sufficient amounts were present for binding to lacO. However, in these U-343lac cells no significant increase in the induction ratio was observed. Second, when the IPTG-inducible RSV-LTR promoter was replaced by an IPTG-inducible MT-1 promoter, which should introduce additional regulation because of its heavy metal induction, again induction ratios could not be substantially increased and did not exceed twofold, although a lower level of noninduced cell death was achieved. The poor regulation of DTA toxicity using the Lac system is apparently related to its inability to repress DTA gene transcription sufficiently. We therefore conclude that the Lac system is not suitable for situations in which efficient repression of transgene expression is mandatory, such as in paradigms involving genes that encode highly potent toxins.
We have obtained regulation of up to 120-fold when using the Tet system, corresponding to data shown previously, in which the expression of reporter genes could be regulated between 15-and 100,000-fold in HeLa cells, and between two-and 5000-fold in various organs of mice that are double transgenic for tTA and a reporter gene. 10, 13 Besides its high regulation, controlled DTA expression by the Tet system offers additional advantages when used in vivo. First, tetracycline as an effector molecule has well-established pharmacological features and is broadly distributed in various tissues following ingestion. To enhance regulated gene expression in the brain, tetracycline derivatives, such as minocycline, with a higher ability to penetrate the blood-brain barrier can be used. Furthermore, although the toxicity of tetracycline is minimum at the concentration needed to regulate promoter activity, it can be replaced by derivatives showing less cytotoxicity and even higher affinity for tTA, such as anhydrotetracycline. 12 Second, several reports have shown that inhibition of protein synthesis by proteins such as diphtheria toxin results in the activation of programmed cell death (apoptosis). 6, 21, 28 Moreover, a significant "bystander" effect occurs in populations of cells induced to undergo programmed cell death. 4, 9, 35 The bystander effect is defined as the eradication of nontransduced tumor cells by transduced tumor cells via mechanisms that have not been completely identified to date. These mechanisms may include exchange of toxic factors by way of gap junctions, uptake of apoptotic vesicles, release of toxic factors, and activation of the immune system. 22 Thus, similar to the bystander effect observed in a population of cells expressing the thymidine kinase gene and exposed to ganciclovir (a prodrug that when incorporated into DNA is toxic to cells), 2 the bystander effect is expected to occur in a population of tumor cells expressing the DTA gene, although in vivo experiments are required for definitively clarifying this point. In this regard, only a fraction of the tumor cells would need to be transduced with DTA for a significant tumoricidal effect. Third, the toxin is targeted to tumor cells in vivo because retroviral vectors transduce only replicating cells, that is, glioma cells and a few reactive glial cells and vascular cells, whereas quiescent parenchymal cells are not transduced. Moreover, possible leakage of DTA from transduced cells is not harmful to normal brain tissue, because the B fragment, which is required for uptake of the toxin, is absent. Fourth, the very low levels of basal gene expression of the retroviral Tet system 33 should increase the number of packaging cells that release viral particles as well as the number of tumor cells transduced with a toxin gene. We therefore hypothesize that this retroviral vector that contains and regulates an adequate toxin gene will enable regulated cytotoxic gene therapy in vivo.
